7,957 peopleAs of 30 January 2025, Nigeria had vaccinated 7,957 people against mpox, with 4,287 receiving the first dose and 3,626 receiving the second dose.
Nigeriampoxobserved 30 January 2025Africa CDCdocument of 72 observations
Gold tier: mechanically validated evidence, with its primary source.
168 evidence items · page 3 / 7
7,957 peopleAs of 30 January 2025, Nigeria had vaccinated 7,957 people against mpox, with 4,287 receiving the first dose and 3,626 receiving the second dose.
Nigeriampoxobserved 30 January 2025Africa CDCdocument of 72 observations
118 genomes118 MPXV genomes were sequenced from cases in Nigeria and Cameroon between 2018 and 2023.
Cameroun · Nigeriampoxobserved 2018 to 2023published 2025Natureeurope_pmcdocument of 5 observations
52 %In the 2022 global mpox outbreak, 52% of confirmed mpox cases with known HIV status were people living with HIV.
Nigeriampoxobserved 2022published 2023AIDS research and human retrovirusesPubMeddocument of 4 observations
22 %When analysing the 107 samples taken from 24 patients at day 14, the proportion of positive samples strongly decreased between day 0 and day 14 at all sites: skin (four [22%] of 18), anus (two [9%] of 22), throat (none of 21), blood (one [5%] of 21), urine (none of 14), and semen (two [9%] of 11).
Nigeriampoxobserved day 14HAL · Unilimdocument of 102 observations
54 %At day 0, MPXV detection was observed in 13 (54%) of 24 semen samples.
NigeriampoxHAL · Unilimdocument of 102 observations
Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — were vaccinating against mpox during January–February 2025.
Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations
100 %At D14, MPXV tests were negative or weakly positive for 21 (100%) of 21 throat samples.
NigeriampoxHAL · Unilimdocument of 102 observations
Côte D’Ivoire, Liberia, Nigeria, and South Africa reported mpox cases belonging to Clade II.
Afrique du Sud · Liberia · NigeriaClade II · mpoxAfrica CDCdocument of 11 observations
9 %At day 14, MPXV detection was observed in 2 (9%) of 22 anal samples.
NigeriampoxHAL · Unilimdocument of 102 observations
0 %At day 14, MPXV detection was observed in 0 (0%) of 21 throat samples.
NigeriampoxHAL · Unilimdocument of 102 observations
54 %At day 0, MPXV detection was less frequent from semen (13 [54%] of 24) than from skin, but more frequent than from blood, urine, or throat.
Nigeriampoxobserved day 0HAL · Unilimdocument of 102 observations
5 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 5 (14.3%) had HIV infection.
Nigeriampox · VIH/sidaobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations
24,250 vaccine_doses24,250 Mpox vaccine doses were prepared for shipment to the Democratic Republic of the Congo, Kenya, Nigeria, and Uganda.
Kenya · Nigeria · Ouganda · RDCmpoxAfrica CDCdocument of 72 observations
71 %MPXV detection was more frequent from anus samples (30 of 42, 71%) than from blood (13 of 45, 29%), urine (9 of 41, 22%), or semen (13 of 24, 54%).
NigeriampoxHAL · Unilimdocument of 102 observations
33 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 33 (94.3%) reported being in a heterosexual relationship.
Nigeriampoxobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations
88 %MPXV was detected in the anus of 88% of patients with confirmed monkeypox at diagnosis.
NigeriampoxHAL · Unilimdocument of 102 observations
26 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, fever was present in 26 cases (74.3%).
Nigeriampoxobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations
22 %At day 14, MPXV detection was observed in 4 (22%) of 18 skin samples.
NigeriampoxHAL · Unilimdocument of 102 observations
27.2 CtViral loads were lower from throat (Ct 27·2) than from skin lesions or anal samples.
Nigeriampoxobserved day 0HAL · Unilimdocument of 102 observations
78 %MPXV positivity rates in semen ranged from 78% to 91% in two series of monkeypox cases.
NigeriampoxHAL · Unilimdocument of 102 observations
31 yearsThe median age of confirmed mpox cases was 31 years (IQR 27–38 years).
Nigeriampoxobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations
22 %At day 0, MPXV detection was observed in 9 (22%) of 41 urine samples.
NigeriampoxHAL · Unilimdocument of 102 observations
78 %MPXV positivity rates in semen ranged from 78% to 91% in two previous series of nine and 32 patients.
NigeriampoxHAL · Unilimdocument of 102 observations
2 casesIn Nigeria in 2018, both of two monkeypox cases were viraemic.
Nigeriampoxobserved 2018HAL · Unilimdocument of 102 observations
6 patientsOf the 107 samples taken at D14, six of 24 patients had samples with a Ct value of less than 35.
NigeriampoxHAL · Unilimdocument of 102 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.